3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Cholangiocarcinoma
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Biliary Tract Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
14
Paclitaxel
12
Carboplatin
11
Specimen Handling
8
Bevacizumab
7
Magnetic Resonance Spectroscopy
6
Taxes
5
Fulvestrant
5
Cisplatin
5
Biopsy
5
olaparib
4
Nivolumab
4
palbociclib
3
Oxaliplatin
3
Megestrol Acetate
3
Leucovorin
3
Letrozole
3
Immunoglobulin G
3
Fluorouracil
3
Doxorubicin
3
Docetaxel
3
Disulfides
3
zanidatamab
2
trastuzumab deruxtecan
2
ribociclib
2
pertuzumab
2
lenvatinib
2
ipatasertib
2
elacestrant
2
durvalumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
futibatinib
×
30 days
×
Clear all
No trials found.